U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403916) titled 'Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer' on Feb. 04.
Brief Summary: Next-generation sequencing (NGS) and biomarkers play a key role in the diagnosis and personalized therapy of gastric cancer. These technologies provide a deep understanding of the molecular basis of the disease.
NGS allows simultaneous analysis of multiple genes, identifying mutations and changes in their expression. In case of stomach cancer, this makes it possible to identify specific mutations to determine prognosis and treatment choice, study the genomic profiles of patients to find targets for target...